SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001140361-23-057007
Filing Date
2023-12-08
Accepted
2023-12-08 16:57:49
Documents
4
Period of Report
2023-12-07

Document Format Files

Seq Description Document Type Size
1 PRE 14A ny20015850x1_pre14a.htm PRE 14A 195669
2 logo_transcode.jpg GRAPHIC 19427
3 ny20015850x1_pc01.jpg GRAPHIC 649162
4 ny20015850x1_pc02.jpg GRAPHIC 581168
  Complete submission text file 0001140361-23-057007.txt   1916993
Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Filer) CIK: 0001829635 (see all company filings)

IRS No.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-40363 | Film No.: 231476170
SIC: 2834 Pharmaceutical Preparations